Stem Cell Meeting on the Mesa is a two-day conference aimed at bringing together the scientific research and business development communities in regenerative medicine to advance stem cell science into cures for debilitating diseases and injuries. The meeting features a nationally recognized Scientific Symposium attended by leading scientists and researchers and hosts the first-ever Investor and Partnering Forum designed to facilitate a bridge between academia and industry through one-on-one meetings and further the translation of clinical research.
This invitation-only program attracts leading scientists, life sciences business executives, and government officials. The aim is to explore the imminent scientific, ethical and business challenges facing stem cell research today. The program is designed around panel discussions that explore topics ranging from basic science and technologies to regulatory considerations.
The Symposium is hosted by the San Diego Consortium for Regenerative Medicine (SDCRM) and managed by CONNECT and in partnership with The Science Network. Established in March 2006, SDCRM is comprised of UC San Diego, Sanford-Burnham Medical Research Institute, Salk Institute for Biological Studies and The Scripps Research Institute. The consortium marshals the intellectual resources of these four world leaders in life sciences research, bringing scientists from each institution together to conduct joint research and training programs in stem cell research.
Epigenetics from Transgenic Mice to Stem CellsA conversation with Rudolf JaenischSpeakers: Rudolf Jaenisch Run Time: 32 minutes Rudolf Jaenisch discusses his early work creating transgenic and knock-out mice, how that lead to his work on epigenetics and stem cells, and... |
Reprogramming CellsA conversation with Sir Ian WilmutSpeakers: Sir Ian Wilmut Run Time: 49 minutes Sir Ian Wilmut discusses how an interest in agriculture led him to research on nuclear transfer in embryos, how that lead to cloning Dolly, and his... |
The Zigzag of ScienceA conversation with Mahendra RaoSpeakers: Mahendra Rao Run Time: 44 minutes Mahendra Rao discusses the zigzag-ing path of translation stem cell research and the shifting global dynamics of science.See his Stem Cell Meeting on... |
A Primer on Stem Cells and TranslationA conversation with Lawrence GoldsteinSpeakers: Lawrence Goldstein Run Time: 45 minutes Lawrence Goldstein discusses the different types of stems cells, what his group learned by creating stem cells lines carrying Craig Venter's genome,... |
iPS technology and disease research: Issues to be resolvedRudolf Jaenisch, KeynoteNovember 30, 2011Topics: Speakers: Rudolf Jaenisch Run Time: 36 minutes Dr. Jaenisch received his doctorate in medicine from the University of Munich in 1967. Before Whitehead, he was head of the Department of Tumor... |
Redirecting cell fate: past, present, and futureSir Ian Wilmut, KeynoteNovember 30, 2011Topics: Speakers: Ian Wilmut Run Time: 38 minutes Dr. Wilmut obtained a B.Sc. in agricultural science at the University of Nottingham before studying at the University of Cambridge, where he was... |
Opening Remarkswith Roger BinghamNovember 30, 2011Topics: Speakers: Roger Bingham Run Time: 03 minutes
|
Welcome Remarkswith Jonathan ThomasNovember 30, 2011Topics: Speakers: Jonathan Thomas Run Time: 17 minutes Dr. Thomas majored in biology and history at Yale, where he graduated summa cum laude. As a George C. Marshall Scholar at Oxford, he then earned a... |
Panel 1: The Science of the Sanford ConsortiumEdward Holmes, Martin Friedlander, Fred Gage, Lawrence Goldstein, Evan SnyderNovember 30, 2011Topics: Speakers: Edward Holmes, Martin Friedlander, Fred Gage, Lawrence Goldstein, Evan Snyder Run Time: 55 minutes Edward Holmes: Dr. Holmes received his M.D. from the University of Pennsylvania. He is the executive deputy chairman of the Biomedical Research... |
Panel 2: Getting There – Translating the Science of Stem CellsIntroduction by Jeanne Loring, Center for Regenerative MedicineNovember 30, 2011Topics: Speakers: Jeanne Loring Run Time: 02 minutes Dr. Loring was co-director of one of the first NIH-supported human embryonic stem cells centers at SBMRI, prior to joining TSRI. Earlier in her... |
Panel 2: Philip Gregory, Sangamo BiosciencesGetting There – Translating the Science of Stem CellsNovember 30, 2011Topics: Speakers: Philip Gregory Run Time: 15 minutes Dr. Gregory has served as chief scientific officer of Sangamo since July 2009 and vice president, research since October 2005. He joined Sangamo in... |
Panel 2: David Piper, Life TechnologiesGetting There – Translating the Science of Stem CellsNovember 30, 2011Topics: Speakers: David Piper Run Time: 14 minutes Dr. Piper received his B.S. in biophysics and B.A. in biochemistry from the University of Illinois before earning his Ph.D. in neuroscience at the... |
Panel 2: Mahendra Rao, National Institutes of Health (NIH)Getting There – Translating the Science of Stem CellsNovember 30, 2011Topics: Speakers: Mahendra Rao Run Time: 22 minutes Dr. Rao is internationally renowned for his research involving human embryonic stem cells (hESCs) and other somatic stem cells. He has worked in the... |
Panel 2: Question and AnswerGetting There – Translating the Science of Stem CellsNovember 30, 2011Topics: Speakers: Jeanne Loring, Philip Gregory, David Piper, Mahendra Rao Run Time: 20 minutes Jeanne Loring: Dr. Loring was co-director of one of the first NIH-supported human embryonic stem cells centers at SBMRI, prior to joining TSRI.... |
Panel 3: CIRM Disease Team ReportsIntroduction by Patricia Olson, California Institute for Regenerative Medicine (CIRM)November 30, 2011Topics: Speakers: Patricia Olson Run Time: 07 minutes Dr. Olson is responsible for the development, implementation and monitoring of the research funding program of CIRM. She is a former vice president... |
Panel 3: Dennis Carson, UC San Diego Moores Cancer CenterCIRM Disease Team ReportsNovember 30, 2011Topics: Speakers: Dennis Carson Run Time: 15 minutes Dr. Carson earned his medical degree from Columbia University and received postgraduate training at The Salk Institute, NIH and UC San Diego. He has... |
Panel 3: Martin Marsala, UC San DiegoCIRM Disease Team ReportsNovember 30, 2011Topics: Speakers: Martin Marsala Run Time: 18 minutes Dr. Marsala has developed and characterized several models of spinal traumatic and ischemic injury and brain ischemia models using rodents and... |
Panel 3: Allan Robins, ViaCyteCIRM Disease Team ReportsNovember 30, 2011Topics: Speakers: Allan Robins Run Time: 15 minutes Dr. Robins received a B.S. with honors in biochemistry and a Ph.D. in molecular biology from the University of Adelaide in Australia. He followed his... |
Panel 3: Inder Verma, Salk Institute for Biological SciencesCIRM Disease Team ReportsNovember 30, 2011Topics: Speakers: Inder Verma Run Time: 14 minutes Dr. Verma received his Ph.D. from Weizmann Institute of Science in Rehovot, Israel, in 1971. He continued his postdoctoral training with David... |
Panel 3: Question and AnswerCIRM Disease Team ReportsNovember 30, 2011Topics: Speakers: Patricia Olson, Dennis Carson, Martin Marsala, Allan Robins, Inder Verma Run Time: 13 minutes Patricia Olson: Dr. Olson is responsible for the development, implementation and monitoring of the research funding program of CIRM. She is a former... |
Panel 4: Stem Cells in Clinical TrialsIntroduction by Catriona Jamieson, Moores UC San Diego Cancer CenterNovember 30, 2011Topics: Speakers: Catriona Jamieson Run Time: 19 minutes Dr. Jamieson received her BS.c. in biology (genetics), Ph.D. in microbiology and M.D. from the University of British Columbia. After completing a... |
Panel 4: Nicholas Boulis, Emory UniversityStem Cells in Clinical TrialsNovember 30, 2011Topics: Speakers: Nicholas Boulis Run Time: 20 minutes Dr. Boulis is a physician scientist whose research interests include biological neurorestoration and neuromodulation through the use of cell, protein... |
Panel 4: Robert Deans, Athersys, Inc.Stem Cells in Clinical TrialsNovember 30, 2011Topics: Speakers: Robert Deans Run Time: 15 minutes Dr. Deans holds degrees from MIT and the University of Michigan, and conducted his postdoctoral training in molecular immunology at UCLA. He is... |
Panel 4: Steven Schwartz, UCLA Diabetic Eye Disease and Retinal Vascular CenterStem Cells in Clinical TrialsNovember 30, 2011Topics: Speakers: Steven Schwartz Run Time: 20 minutes Dr. Schwartz’ primary areas of research include early diagnosis and treatment of diseases such as retinopathy of prematurity (ROP), diabetic... |
Panel 4: Question and AnswerStem Cells in Clinical TrialsNovember 30, 2011Topics: Speakers: Catriona Jamieson, Nicholas Boulis, Robert Deans, Steven Schwartz Run Time: 24 minutes Catriona Jamieson: Dr. Jamieson received her BS.c. in biology (genetics), Ph.D. in microbiology and M.D. from the University of British Columbia.... |